Bob Bradway, Amgen CEO (Justin Kase Conder/AP Images for Amgen)

Am­gen chief Brad­way nabs a rare dis­ease play­er in $4B buy­out as the M&A tem­po ac­cel­er­ates

Am­gen CEO Bob Brad­way is bel­ly­ing up to the M&A ta­ble to­day, scoop­ing up the new­ly anoint­ed com­mer­cial biotech Chemo­Cen­tryx $CCXI and its re­cent­ly ap­proved …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.